# Equivalence of the Response to Vaccination of Tacrolimus Ointment to a Steroid Ointment Regimen in Children With Atopic Dermatitis

> **NCT00801957** · PHASE2 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 260 (actual)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DRUG:** tacrolimus ointment 0.03%
- **DRUG:** hydrocortisone acetate ointment 1%
- **DRUG:** hydrocortisone butyrate ointment 0.1%
- **BIOLOGICAL:** Meningitec
- **BIOLOGICAL:** AC VAX

## Key facts

- **NCT ID:** NCT00801957
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-03
- **Primary completion:** 2004-11
- **Final completion:** 2004-11
- **Target enrollment:** 260 (ACTUAL)
- **Last updated:** 2014-09-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00801957

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00801957, "Equivalence of the Response to Vaccination of Tacrolimus Ointment to a Steroid Ointment Regimen in Children With Atopic Dermatitis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00801957. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*